drugset / Trial / NCT03035929

Diagnosing Natriuretic Peptide Deficiency

NCT03035929 ↗

Phase 1 Completed 10 enrolled Vanderbilt University Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

In this pilot study, the investigators will determine the response of the natriuretic peptide (NP) hormone system after a dose of intravenous dexamethasone (a steroid medication). The goal of the proposed project is to generate preliminary data that will be used to develop power calculations, inform cutoff ranges, and inform the timing of the NP response for larger subsequent studies. Aim: To determine the range of distribution and time course of natriuretic peptide (NP) responses to a single dose of dexamethasone IV 4 mg in healthy lean individuals. Hypothesis: Determination of the NP responses (the range and time course of changes in NP levels) to dexamethasone in 10 healthy individuals will inform the time course and frequency of blood sampling in a definitive prospective study, as well as enable investigators to perform a sample size calculation for a definitive prospective study.

Timeline

Start
2017-01-01
Primary completion
2017-06-08
Completion
2018-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Intravenous

Indications

No indication recorded.